发明名称 USE OF SODIUM CHANNEL BLOCKER IN THE MANUFACTURE OF A MEDICAMENT FOR PREVENTING OPTIC NERVE DEGENERATION ASSOCIATED WITH GLAUCOMA
摘要 <p>A method and composition for altering a plausible sequence of pathological events in retinal ganglion cells associated with glaucoma, the sequence including membrane depolarization, influx of millimolar amounts of Na+ via non-inactivating Na+ channels, and the lethal elevation of cell Ca2+ due to reversal of the Na+ exchanger. The method includes blocking, by administration of a selected composition, of associated, non-inactivating Na+ channels in retinal ganglion cells in order to limit Na+/Ca2+ exchange in the retinal ganglion cells and prevent buildup of the Ca2+ level in the retinal ganglion cells to a lethal level. The results in a method of preventing retinal ganglion cell death, associated with glaucoma, by administering to the optic nerve of a mammal, a compound which blocks the non-inactivating sodium ion channels of the optic nerve. Alternately, said invention relates to a method of preventing optic retinal ganglion cell death in a human by administering to the retinal ganglion cells of said human a compound which blocks the non-inactivating sodium ion channel of the retinal ganglion cells.</p>
申请公布号 WO1998043612(A1) 申请公布日期 1998.10.08
申请号 US1998005941 申请日期 1998.03.26
申请人 发明人
分类号 主分类号
代理机构 代理人
主权项
地址